These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38905108)

  • 1. A Broad-specificity Neutralizing Nanobody against Hepatitis E Virus Capsid Protein.
    Wang X; Sheng Y; Ji P; Deng Y; Sun Y; Chen Y; Nan Y; Hiscox JA; Zhou EM; Liu B; Zhao Q
    J Immunol; 2024 Aug; 213(4):442-455. PubMed ID: 38905108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
    Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
    J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.
    Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM
    J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4.
    Wen J; Behloul N; Dai X; Dong C; Liang J; Zhang M; Shi C; Meng J
    Antiviral Res; 2016 Apr; 128():36-42. PubMed ID: 26850829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
    Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
    Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus.
    Ji P; Zhu J; Li X; Fan W; Liu Q; Wang K; Zhao J; Sun Y; Liu B; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Mar; 18(1):44. PubMed ID: 32169061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.
    Larralde O; Petrik J
    Med Microbiol Immunol; 2017 Aug; 206(4):301-309. PubMed ID: 28434129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus.
    Cai W; Tang ZM; Wen GP; Wang SL; Ji WF; Yang M; Ying D; Zheng ZZ; Xia NS
    Sci Rep; 2016 Apr; 6():25141. PubMed ID: 27122081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel linear neutralizing epitope of hepatitis E virus.
    Tang ZM; Tang M; Zhao M; Wen GP; Yang F; Cai W; Wang SL; Zheng ZZ; Xia NS
    Vaccine; 2015 Jul; 33(30):3504-11. PubMed ID: 26051517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.
    Zhang H; Dai X; Shan X; Meng J
    Virus Res; 2009 Jun; 142(1-2):140-3. PubMed ID: 19428747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Zheng M; Jiang J; Zhang X; Wang N; Wang K; Li Q; Li T; Lin Q; Wang Y; Yu H; Gu Y; Zhang J; Li S; Xia N
    Vaccine; 2018 Apr; 36(16):2104-2111. PubMed ID: 29544686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus.
    Haqshenas G; Huang FF; Fenaux M; Guenette DK; Pierson FW; Larsen CT; Shivaprasad HL; Toth TE; Meng XJ
    J Gen Virol; 2002 Sep; 83(Pt 9):2201-2209. PubMed ID: 12185274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.
    Gu Y; Tang X; Zhang X; Song C; Zheng M; Wang K; Zhang J; Ng MH; Hew CL; Li S; Xia N; Sivaraman J
    Cell Res; 2015 May; 25(5):604-20. PubMed ID: 25793314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals.
    Chen Y; Zhang M; Chen T; Wang J; Zhao Q; Zhou EM; Liu B
    Microbiol Spectr; 2023 Aug; 11(4):e0360722. PubMed ID: 37347160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.